Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | pheneticillin | 272833 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | pheneticillin | 272833 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | pheneticillin | 272833 | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | pheneticillin | 272833 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | pheneticillin | 272833 | drug-path |
| Small cell lung cancer | R-HSA-5619066 | map05222 | pheneticillin | 272833 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | propidium iodide | 5281847 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | propidium iodide | 5281847 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | propidium iodide | 5281847 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | propidium iodide | 5281847 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | propidium iodide | 5281847 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | propidium iodide | 5281847 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | propidium iodide | 5281847 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | propidium iodide | 5281847 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | PF-01378883-00 | None | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | PF-01378883-00 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | PF-01378883-00 | None | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | PF-01378883-00 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | PF-01378883-00 | None | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | PF-01378883-00 | None | drug-path |